Donate
News + Publications
Careers
Donate
Contact
Back
Who
We Are
Board of Directors + Governance
Our Leadership
Our Team
Our Partners
Our Benefactors
Our History
Health Impact Reports
Our
Programs
All Programs
Accelerating Medicines Partnership® (AMP®)
Accelerating COVID-19 Therapeutic Interventions & Vaccines (ACTIV)
Alzheimer’s Disease Neuroimaging Initiative (ADNI)
Biomarkers Consortium
GeneConvene Global Collaborative
Azithromycin Prevention in Labor Use Study (A-PLUS)
Master Protocol for Treatment of Non-Small Cell Lung Cancer (Lung-MAP)
Partnership For Accelerating Cancer Therapies (PACT)
Edmond J. Safra Family Lodge
Global Pandemic Treaty
All of Us Research Program
Education & Training Programs
Fighting
Diseases
All Disease
Cancer
Cardiovascular
Infectious Diseases
Inflammation + Immunology
Maternal, Child + Newborn Health
Metabolic Disorders
Neuroscience
Rare Diseases
Powering
Science
FNIH Awards Ceremony
The Lurie Prize in Biomedical Sciences
Trailblazer Prize for Clinician-Scientists
Charles A. Sanders, MD Partnership Award
The Deeda Blair Research Initiative for Disorders of the Brain
Research Support
Fellowships & Training
Lectures
Patient
Voices
Donate
Partner With Us
All Programs
Home
Our Programs
All Programs
Program Type
-Any-
Awards & Prizes
Fellowship & Training
Fighting Diseases (Research)
Lectures
Research Support
Disease
-Any-
Acute Myeloid Leukemia (AML)
Adult Acute Lymphoblastic Leukemia (ALL)
Aging
Alcohol use
All Diseases
Alzheimer’s Disease
Arthritis
Atherosclerosis
Autoimmune Diseases
Blood Disorders
Breast Cancer
Cancer
Cardiovascular Diseases
Cell and Gene Therapy
Colorectal Cancer
COVID-19
Dementia
Diabetes
Digestive Diseases
Drug Abuse
Ebola
Frailty
Genetic Disorders
Genetics
Genetics and Genomics
Global Health
Heart Disease
Hematology
HIV
Immuno-Oncology
Infectious Diseases
Inflammation and Immunology
Influenza
Kidney Cancer
Kidney Disease
Liquid Biopsy
Liver Disease
Lung Cancer
Lymphoma
Malaria
Maternal/Women's Health
Metabolic Disorders
Muscular Dystrophy
Musculoskeletal Disorders
Native American health
Neglected Tropical Diseases
Neuroscience
Non-alcoholic Fatty Liver Disease (NAFLD)
Non-Alcoholic Steatohepatitis (NASH)
Obesity
Opioid Use Disorder
Osteoarthritis
Osteoporosis
Parkinson’s Disease
Pediatric Health
Pharmacology
Postpartum Anemia
Prostate Cancer
Rare Diseases
Rheumatoid Arthritis
Schizophrenia
Sports Injuries
Tuberculosis
Ulcerative Colitis
Vision Health
Vision Research
Project Status
-Any-
Active Projects
Completed Projects
In Development
In Fundraising
Displaying 76 - 90 of 90
Charles A. Sanders, MD Partnership Award
In honor of its former Chairman of the Board, the FNIH celebrates its partners through the Charles A. Sanders, MD, Partnership Award. The aw...
Trailblazer Prize for Clinician-Scientists
The Trailblazer Prize for Clinician-Scientists (Trailblazer Prize) recognizes the outstanding contributions of early career clinician-scient...
AMP Type 2 Diabetes
AMP Common Metabolic Disorders
The Accelerating Medicines Partnership® (AMP®) Program in Common Metabolic Diseases (AMP CMD) is a collaborative partnership among governm...
Azithromycin Prevention in Labor Use Study (A-PLUS)
Partnership For Accelerating Cancer Therapies (PACT)
AMP Autoimmune & Immune-Mediated Diseases
The Accelerating Medicines Partnership® (AMP®) Program Autoimmune and Immune-Mediated Diseases (AMP AIM) is a precompetitive partnership t...
AMP Alzheimer’s Disease 1.0
Fusce volutpat nunc non lectus interdum, vitae sollicitudin lacus condimentum. Pellentesque vel nisl. Fusce volutpat nunc non lectus interdu...
AMP Schizophrenia
The Accelerating Medicines Partnership® (AMP®) Program Schizophrenia (AMP SCZ) is the first neuropsychiatric project of the landmark AMP p...
AMP Parkinson’s Disease
The Accelerating Medicines Partnership® (AMP®) Program Parkinson’s disease (AMP PD) is a public-private partnership among NIH and privat...
AMP Heart Failure
The Accelerating Medicines Partnership® Heart Failure program (AMP® HF) is focused on a major unmet need in cardiovascular health. AMP HF ...
AMP Alzheimer’s Disease 2.0
The Accelerating Medicines Partnership® (AMP®) Program Alzheimer’s disease (AMP AD 2.0) is a precompetitive public-private partnership t...
AMP® Bespoke Gene Therapy Consortium (BGTC)
The Accelerating Medicines Partnership® (AMP®) Program Bespoke Gene Therapy Consortium (AMP BGTC) brings together partners from the public...
Accelerating COVID-19 Therapeutic Interventions & Vaccines (ACTIV)
Accelerating Medicines Partnership® (AMP®)
Our mission is to improve understanding of disease pathways, facilitate better selection of targets for treatment and identify platforms and...
Prev
1
2
3
4
Diseases
Learn More
Partner With Us
Let’s Collaborate
